A23V 2400/535
Pseudocatenulatum
A23V2400/535 (Pseudocatenulatum) appears on 12 US grants and 24 published applications in this corpus.
Search patents in A23V- Granted patents
- 12
- Published applications
- 24
- Assignees
- 11
- Inventors
- 47
- Latest grant
- 3 Jun 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 2 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 5 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 2 |
| 2015 | 1 | 2 |
| 2016 | 0 | 2 |
| 2017 | 2 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 2 |
| 2020 | 0 | 0 |
| 2021 | 1 | 3 |
| 2022 | 1 | 3 |
| 2023 | 3 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Bifidobacterium genus bacterium having high capacity to utilize polysaccharides of dietary origin3 Jun 2025US 12,318,416 B2Kabushiki Kaisha Yakult Honsha
- Freeze-dried nipa palm powder and method of manufacturing the same5 Dec 2023US 11,833,184 B1Vinamit Jsc.
- Methods for the isolation of microbes with enhanced persistance and compositions with such microbes12 Sep 2023US 11,752,178 B2NUtech Ventures
- Food composition and pharmaceutical composition for inhibiting Sjogren's syndrome each containing Bifidobacterium pseudocatenulatum C-RAPO (KCTC13986BP) and Bifidobacterium bifidum ATT (KCTC13474BP)18 Jul 2023US 11,701,395 B2Bifido Co., Ltd.
- Food composition and pharmaceutical composition for inhibiting Sjogren's syndrome each containing Bifidobacterium pseudocatenulatum C-RAPO (KCTC13986BP) and Bifidobacterium bifidum ATT (KCTC13474BP)22 Feb 2022US 11,253,555 B2Bifido Co., Ltd.
- Novel bacterium belonging to genus bifidobacterium24 Sep 2026US 2026/0286283 A1Kabushiki Kaisha Yakult Honsha
- Beneficial bacteria and secretory immunoglobulin a8 Sep 2022US 2022/0280581 A1The Regents of the University of California
- Food composition and pharmaceutical composition for inhibiting sjogren's syndrome each containing bifidobacterium pseudocatenulatum c-rapo (kctc13986bp) and bifidobacterium bifidum att (kctc13474bp)7 Jul 2022US 2022/0211775 A1Bifido Co., Ltd.
- Novel bifidobacterium genus bacterium having high capacity to utilize polysaccharides of dietary origin26 May 2022US 2022/0160795 A1Kabushiki Kaisha Yakult Honsha
- Food composition and pharmaceutical composition for inhibiting sjogren's syndrome each containing bifidobacterium pseudocatenulatum c-rapo (kctc13986bp) and bifidobacterium bifidum att (kctc13474bp)23 Sep 2021US 2021/0290696 A1Bifido Co., Ltd.
Most cited
By later US patents
- Preventing diseases in infants delivered via caesarean section6US 8,715,769 B2N. V. Nutricia · 2014
- Conjugated linoleic acid isomerase and a process for the production of conjugated linoleic acid3US 7,223,543 B2Teagasc Dairy Products Research Centre · 2007
- Food composition and pharmaceutical composition for inhibiting Sjogren's syndrome each containing Bifidobacterium pseudocatenulatum C-RAPO (KCTC13986BP) and Bifidobacterium bifidum ATT (KCTC13474BP)1US 11,701,395 B2Bifido Co., Ltd. · 2023
- Preventing diseases in infants delivered via caesarean section1US 9,107,438 B2N. V. Nutricia · 2015
- Method for stimulating the intestinal flora1US 9,596,876 B2N. V. Nutricia · 2017